European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework ...

Abbott has put the ball back in Serena Williams’ court to serve up a high-profile endorsement of the Lingo over-the-counter ...

After beefing up the target of its global cost-savings drive once again, Pfizer is continuing to see its plan through with ...

After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the ...

About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...

The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release ...

Supreme Group has consolidated two of the companies it bought during a nine-deal, 18-month splurge, combining Amendola ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...

A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...

The new Lilly facilities—which include a $5 billion API plant near Richmond, Virginia, which was announced in September—are ...